Literature DB >> 34622378

Comparative Utility of Transient and 2D Shear Wave Elastography for the Assessment of Liver Fibrosis in Clinical Practice.

Dimitrios S Karagiannakis1, Theodoros Voulgaris2, Theodoros Angelopoulos2, Panagiota Ioannidou2, Evangelos Cholongitas3, Jiannis Vlachogiannakos2, George V Papatheodoridis2.   

Abstract

The aim of the study was to investigate the feasibility and correlation of liver stiffness measurements (LSM) between 2D-shear wave elastography (2D-SWE) and transient elastography (TE) in patients with chronic liver disease. Over 4 months, 421 patients with chronic liver disease of any cause underwent LSM by 2D-SWE and TE (M and/or XL probe) and controlled attenuation parameter at the same visit. LSM was not feasible by TE in 16 (3.8%) and by 2D-SWE in 17 (4.0%) patients. Median LSM were 8.9 and 8.7 kPa with TE and 2D-SWE, respectively, having a strong correlation (r = 0.774, p < 0.001) in the total cohort and in any cause of liver disease (r = 0.747-0.806, p < 0.001). There was a strong agreement on diagnosis of severe fibrosis (k-statistic: 0.841, p < 0.001) or cirrhosis (k-statistic: 0.823, p < 0.001). Both methods had increased failure rates in patients with obesity and/or increased waist circumference. Among 104 obese patients, TE was more feasible than 2D-SWE (92.3% vs 85.6%, p < 0.001]. LSM by 2D-SWE are strongly correlated to LSM by TE independently of the etiology of chronic liver disease, stage of fibrosis, degree of liver steatosis, and patients' characteristics. TE with the XL probe may be superior in a minority of obese patients.
© 2021. Society for Imaging Informatics in Medicine.

Entities:  

Keywords:  2D-shear wave elastography; Liver fibrosis; Liver stiffness; Transient elastography

Mesh:

Year:  2021        PMID: 34622378      PMCID: PMC8669084          DOI: 10.1007/s10278-021-00521-7

Source DB:  PubMed          Journal:  J Digit Imaging        ISSN: 0897-1889            Impact factor:   4.903


  1 in total

1.  Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations.

Authors:  Laurent Castéra; Juliette Foucher; Pierre-Henri Bernard; Françoise Carvalho; Daniele Allaix; Wassil Merrouche; Patrice Couzigou; Victor de Lédinghen
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

  1 in total
  2 in total

1.  Noninvasive Pediatric Liver Fibrosis Measurement: Two-Dimensional Shear Wave Elastography Compared With Transient Elastography.

Authors:  Léa Chantal Tran; Delphine Ley; Gurvan Bourdon; Stéphanie Coopman; Héloïse Lerisson; Céline Tillaux; Hélène Béhal; Frédéric Gottrand; Madeleine Aumar
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.418

2.  Fibroscan® and Shear Wave correlated well in hepatic fibrosis evaluation of patients with chronic liver diseases "in real life situation".

Authors:  Honoré Tegwendé Zougmoré; Jean François David Cadranel; Gildas Fantognon; Badia Azzi; Ryad Smadhi; Jean René Ngele Efole; Samir Mrabti; Ratmony Heng; Marie Adrienne Ntsama; Mourad Medmoun; Firouzeh Kazerouni; Tristan Le Magoarou
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.